CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Grant or award Vice President, Finance acquired 16,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 45,000 shares (grant or award)
- 4 Grant or award President and COO acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Medical Officer sold 22,300 shares at an average $19.20 ($428,050)
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 43,800 shares at an average $22.74 ($995,874)
- 4 Open-market sale Chief Medical Officer sold 19,175 shares at $18.12 ($347,405)
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 22 of 32 · 631 filings